Precursor Condition
Cervical Squamous Intraepithelial Neoplasia
CI-CAN-00002175CINExplore in graph →
Precursor3 active trials
- NCIt
- C7346
Loading cancer entity…
Loading cancer entity…
Precursor Condition
CI-CAN-00002175CINExplore in graph →
Clinical trials
19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05210348 | Clinical Evaluation of Detection of High Risk HPV in Urine(Urine-hrHPV) | unknown | — | 1,000 | Peking University People's HospitalOTHER | 1 | Jan 27, 2022 |
| clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00343213 | Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix. | unknown | N/A | 300 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 30, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Apr 17, 2024source: clinicaltrials